Product :

•           Technology, devices and methodical references engineering of AMI, CHF è ECR treatment by ferromagnetic nano-particles including in human mesenchymal stem cells with using of bioreactor and  

           myocardium environment activation for confirmation in the Public Health Ministry and Social Development of Russian Federation

.

•          Development of  original technologies and devices  for stem cells address delivery  with 3-D system,  based on improved device “ELKART-NAVIGATOR” , hollow inside    controllable catheters for MSC injection in myocardium  for confirmation  in the Public Health Ministry and Social Development of Russian Federation.

•          Engineering device for external magnetic field creation behind patient heart with biocomposits immobilization on the basis of  MSC and FNM.  

•            Creation of study program and  references with lection course and  practical training  for scientists education of new working methods with stem cells, bioengineering, nanotechnology, with using of advanced device “ELKART-NAVIGATOR”    for  cardiovascular diseases (CVD) treatment.   

Competitors

        There are few  experiments in the world of using magnetic nano-particles with stemm cells.

        According to the information that we found in articles, books, conference materials,  we didn’t find any technology analog of safety   nanoferretics  including in  MSC  without changes of their   clonogenic  è morphofunctional characteristics.  

       There is one nearest  -  Electro anatomical analysis NOGA, CARTO system Biosense Vebster (USA)

       Works with cell material preparation  was on unsufficient level, in fact  they work with agnogenic mononuclears.

This operations still have no authentic results.

 Our advantages:

 In comparison with surgical methods of CVD diseases treatment will cost cheaper, period of staying in hospital will be shorter, quality of treatment CVD and quality of patient lifestyle will be better , level of population invalidization will be lower too.

Biotechnologies  – is the nearest future of modern medicine.

 Project group

·         ELECTROPULSE more than 20 years develop, produce, sertificate and sell diagnostic  and cardiovascular disease  treatment device.

In 1990 specialists of this company create first in USSR and on the first in Europe radiofrequent destructor (ablator) for endocardial treatment of arrhythmia.

In this project we use ablator for myocardium environment activation.

In 1995 was created first variant of ELCART system -  cardiac electrophysiological researchments system for to detection of  cardiac rhythm disturbance.          

In 2008 the last modification ELCART2 – was complemented with navigation system, or with visualization system of internal heart cavity (3D – image).